Remove conferences 2022-biotechnology-conference
article thumbnail

Message From The Chair: Why Attend The 2023 ISPE Biotechnology Conference

ISPE

Message From The Chair: Why Attend The 2023 ISPE Biotechnology Conference Trudy Patterson Wed, 03/22/2023 - 12:08 iSpeak Blog iSpeak Message From The Chair: Why Attend The 2023 ISPE Biotechnology Conference Liz M. Dooley, MSc. Dooley, MSc.

FDA 98
article thumbnail

2022 ISPE Biotechnology Conference: Ongoing Growth & Development

ISPE

2022 ISPE Biotechnology Conference: Ongoing Growth & Development. Fri, 10/28/2022 - 08:14. November / December 2022. 2022 ISPE Biotechnology Conference: Ongoing Growth & Development. 1 November 2022. Trudy Patterson. Susan Sandler. The Road to Advanced Manufacturing.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

SMi’s 6th Annual Highly Potent Active Pharmaceutical Ingredients

pharmaphorum

9th and 10th May 2022. SMi Group are delighted to announce the 6th Annual Highly Potent Active Pharmaceutical Ingredients Conference will be taking place on 9th – 10th May 2022 in London, UK. Benefits of Attending the HPAPI Conference: •Dissect comprehensive hazard assessment and occupational exposure limit determination.

52
article thumbnail

Ophthalmic Drugs Conference

pharmaphorum

Ophthalmic Drugs Conference. 21 – 22 November 2022 | London, UK. SAE Media Group’s 5th Annual Ophthalmic Drugs Conference will explore advancements in ophthalmic treatments and variety of novel drugs, which are showing good clinical trial data. The post Ophthalmic Drugs Conference appeared first on.

article thumbnail

ISPE Europe Annual Conference, 8th to 10th May 2023 - What You Need to Know about the GAMP® Track!

ISPE

ISPE Europe Annual Conference, 8th to 10th May 2023 - What You Need to Know about the GAMP® Track! Trudy Patterson Fri, 03/03/2023 - 13:15 iSpeak Blog iSpeak ISPE Europe Annual Conference, 8th to 10th May 2023 - What You Need to Know about the GAMP® Track! Looking forward to seeing you at the conference! Learn More & Register!

article thumbnail

IP is no barrier to COVID vaccine access, says industry

pharmaphorum

The Quad compromise, a World Health Organization plan which would, if enacted, release members from granting or enforcing COVID-19 vaccine patents, was discussed at the 12th Ministerial Conference (MC12) last week. As of June 2022 , more than 5.22 However, there is still a huge disparity in access across the globe.

article thumbnail

“I’m Listening,” Says the PTO

The FDA Law Blog

Registration to speak at the conference closes on January 5, 2023. The USPTO responded to FDA’s letter on July 6, 2022, citing its intent to enhance collaboration with other agencies; improve procedures for obtaining a patent; improve the PTAB challenge practice; and improve public participation.

FDA 52